Real-Life Application at Health Express Clinics At our Lewisville location, we have developed a structured weight loss protocol for patients eligible for Tirzepatide: Initial Evaluation Includes: BMI and waist circumference analysis Comprehensive lab panel (A1c, lipids, liver function, TSH) Screening for contraindications (pancreatitis, gallbladder disease, medullary thyroid carcinoma) Ongoing Monitoring Includes: Monthly follow-up appointments (in-person or virtual) Titration of Tirzepatide dosage based on tolerance Nutrition and physical activity coaching GI side effect management (if needed) Common Clinical Scenarios: A 52-year-old woman with PCOS and insulin resistance A 45-year-old male with NAFLD and borderline diabetes A patient who plateaued on semaglutide and transitioned to Tirzepatide for greater effect When patients transition from semaglutide to Tirzepatide, we often see a second wave of weight loss
The Wegovy pill is 25 mg and licensed specifically for weight management in adults with obesity or overweight and a weight-related health condition
The persuasive factor in oral tirzepatide is sustainability
The slow and consistent digestion is, however, only one part of the chain reaction that makes semaglutide such an effective weight loss drug
Rapid or unsupervised discontinuation of tirzepatide carries a significant risk of weight regain
The FDA approves medications at specific dose ranges studied in clinical trials
